Mutation
The putative cancer-causing PDGs driven by somatic mutations were predicted by integration of five complementary methods to identify the genes with mutations that have significant signs of positive selection during tumor evolution.
| Showing page 1 |
first page | previous page | next page | last page |
| HGNC Symbol | Ensembl Gene ID | Overall_Mscore | No. of Cancer Types |
| CTNNB1 | ENSG00000168036 | 3.55 | 10 |
| EGFR | ENSG00000146648 | 2.15 | 4 |
| FAT1 | ENSG00000083857 | 1.31 | 2 |
| RYR2 | ENSG00000198626 | 0.00 | 0 |
| ERBB2 | ENSG00000141736 | 0.85 | 6 |
| B2M | ENSG00000166710 | 0.79 | 3 |
| PTPRD | ENSG00000153707 | 0.27 | 1 |
| ERBB3 | ENSG00000065361 | 0.60 | 3 |
| KIT | ENSG00000157404 | 0.66 | 2 |
| ERBB4 | ENSG00000178568 | 0.00 | 0 |
| C3 | ENSG00000125730 | 0.00 | 0 |
| MET | ENSG00000105976 | 0.31 | 1 |
| LAMA2 | ENSG00000196569 | 0.21 | 1 |
| KDR | ENSG00000128052 | 0.14 | 1 |
| FLT3 | ENSG00000122025 | 0.23 | 2 |
| A2M | ENSG00000175899 | 0.10 | 1 |
| FGFR2 | ENSG00000066468 | 0.42 | 3 |
| ACVR2A | ENSG00000121989 | 0.40 | 4 |
| FGFR3 | ENSG00000068078 | 0.63 | 3 |
| EPHA2 | ENSG00000142627 | 0.27 | 2 |
|
Showing page 1 |
first page | previous page | next page | last page |